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Brock et al. present a novel mutation of
VHL, a marginally stable protein that
displays significantly enhanced stability
in yeast. The structural basis for this
effect, which was determined
computationally and experimentally, is an
increased ability to interact with a
homologous cofactor present in yeast.
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The human von Hippel-Lindau (VHL) tumor suppres-
sor is a marginally stable protein previously used as
a model substrate of eukaryotic refolding and degra-
dation pathways. When expressed in the absence of
its cofactors, VHLcannot foldand isquicklydegraded
by the quality control machinery of the cell. We
combined computationalmethodswith in vivo exper-
iments to examine thebasis of themisfoldingpropen-
sity of VHL. By expressing a set of randomly mutated
VHLsequences in yeast,wediscoveredamore stable
mutant form. Subsequent modeling suggested the
mutation had caused a conformational change
affecting cofactor and chaperone interaction, and
this hypothesis was then confirmed by additional
knockout and overexpression experiments targeting
a yeast cofactor homolog. These findings offer a
detailed structural basis for the modulation of quality
control fate in amodelmisfoldedprotein andhighlight
burial mode modeling as a rapid means to detect
functionally important conformational changes in
marginally stable globular domains.
INTRODUCTION
To function properly in the cell, a globular protein chain typically
must remain folded into a specific conformation or set of confor-
mations known as its native state. A primary determinant of how
a globular protein folds is its amino acid sequence, which fixes
the pattern of internal and external forces that act on the poly-
peptide chain in the aqueous environment. When a protein
cannot reach or cannot maintain its native conformation in the
cell, it is considered to be in a misfolded state, which is often
accompanied by a loss of cellular function. Misfolded proteins
also exhibit a marked tendency to associate non-specifically
and sometimes form potentially cytotoxic aggregates if left to
accumulate in the crowded intracellular environment (Amen
and Kaganovich, 2015; Chiti and Dobson, 2006, 2009; Luby-Phelps, 2000). A large range of globular proteins have been
shown to form amyloid fibrils under partially denaturing condi-
tions (Chiti and Dobson, 2009). Mutations or stochastic pro-
cesses that lead to protein misfolding and/or aggregation have
been implicated in proteinopathies such as Huntington’s,
Alzheimer’s, Parkinson’s, and the prion-based Creutzfeldt-
Jakob disease, emphasizing a need to better understand the
cellular response to protein misfolding in the context of the phys-
ical driving forces that govern how an amino acid sequence can
reach its native structure (Mulligan and Chakrabartty, 2013).
The protein quality control (PQC) machinery consists of the
cellular pathways linked to protein folding and misfolding. Chap-
erone proteins, a key component of PQC systems, can either
assist a misfolded protein in refolding or target incorrect con-
formations for destruction through the ubiquitin proteasome
pathway or autophagy (Kim et al., 2013). Despite the prevalence
of PQC machinery across organisms, many aspects of the sys-
tem are not well understood.Misfolded proteins are able to reach
awide variety of different non-native states, and thePQCmust be
able to recognize this diverse group of conformations either to
assist refolding or to target them for destruction before the mis-
folded polypeptide can detrimentally affect the cell. Hsp70, a
pleiotropic heat-shock-induced chaperone conserved from bac-
teria to eukaryotes, hasbeenshown to recognize exposedhydro-
phobic sites, particularly short (5–7 residues) hydrophobic
sequences flanked by positively charged amino acids (Marci-
nowski et al., 2013; Ru¨diger et al., 1997). The eukaryotic chaper-
onin TRiC, on the other hand, has eight distinct subunits, which
are each capable of recognizing distinct motifs in a variety of
substrates, with mutations in different subunits leading to
different cellular phenotypes (Amit et al., 2010; Spiess et al.,
2006). Because the outcome of the PQC triage decision must
ultimately depend on the structure of a protein, investigating
the role of small conformational perturbations in the sensitivity
of a misfolded protein to the QC machinery can indicate how
the fate of a PQC substrate is modulated for typical substrates.
Marginally stable proteins, which can misfold easily and exist
at a tipping point between stable conformations and PQC-tar-
geted misfolded variants, have been used as an experimental
mechanism to explore PQC substrate recognition and subse-
quent refolding and degradation pathways. The human von
Hippel-Lindau (VHL) protein is one such example that isStructure 23, 1169–1178, July 7, 2015 ª2015 The Authors 1169
particularly susceptible to incorrect folding. This model misfold-
ing protein forms part of an E3 ubiquitin ligase complex that tar-
gets molecules like HIF-1a for degradation, and has been cata-
loged in depth because hundreds of mutant forms have been
linked to cancer pathways in humans (Nordstrom-O’Brien
et al., 2010). The first 60 residues of VHL remain disordered
in the native state; however, the 213-residue protein as a whole
must traverse a distinct folding pathway in vivo, including inter-
acting with chaperones such as Hsp70 and TRiC and binding
with its cofactors elongin B and elongin C, to achieve a state
resistant to cellular degradation (McClellan et al., 2005; Schoen-
feld et al., 2000). For TRiC, two short motifs in the VHL sequence
(Box 1 and Box 2) have been shown to be necessary and suffi-
cient for TRiC binding to VHL in yeast (Feldman et al., 2003).
When folded correctly in complex with its cofactors, the non-
disordered region adopts a well-defined tertiary structure; how-
ever, the protein adopts a molten globule state without its bind-
ing partners in vitro that consists of a partially collapsed state
with some secondary structure but no tertiary structure (Sutov-
sky, 2004). This molten globule state indicates that VHL has dif-
ficulty achieving its native state without interactions with other
proteins. Perturbations to the system, including mutations to
VHL, often lead to a misfolded or otherwise non-functional
version of the protein in vivo (Hansen et al., 2002; Knauth et al.,
2006). When VHL is introduced into non-native systems like
Saccharomyces cerevisiae or Escherichia coli, where it does
not exist naturally, the protein cannot achieve a biologically sta-
ble state and in yeast is quickly degraded by the cell (Kaganovich
et al., 2008; Melville et al., 2003; Sutovsky, 2004; Weisberg et al.,
2012; Ogrodnik et al., 2014). Since VHL is a protein with a typical
state that is poised between adequate folding and being tar-
geted for destruction in yeast, it is ideal for use as a probe of
how different folds (or misfolded variants) can lead to diverse
outcomes through PQC pathways.
One of the persistent difficulties in understanding the physical
mechanisms of protein misfolding and subsequent PQC interac-
tions is that almost by definition, misfolded proteins are not
amenable to conventional methods of structural characteriza-
tion. Protein chains that adopt many different conformations
cannot be crystallized easily, and aggregation-prone proteins
are difficult to solubilize for in vitro characterization. Thus, in
examining the effects of different mutations on a marginally sta-
ble protein like VHL, a computational model that could give
insight into the resulting structural changes could offer a new
and much needed perspective on the connection between
sequence, structure, and recognition by PQC machinery for a
large number of sequences. Recently, we developed a phenom-
enological model to predict tertiary structural information from
sequence alone in globular proteins, which has shown promise
as a method of computationally exploring the allowed conforma-
tional space of fluctuating protein folds (England, 2011). The
burial trace is computed by minimizing an energy function con-
sisting of the hydropathies of each residue and the stretching be-
tween neighbor amino acids, subject to steric constraints. The
calculation generally takes less than a second to run for short se-
quences, and adding noise to the parameters of the system can
generate an ensemble of amino acid burial patterns for a given
protein sequence, which can be used to investigate the vari-
ability in structures that a protein can adopt. The rapidity of1170 Structure 23, 1169–1178, July 7, 2015 ª2015 The Authorsthis model in determining structural information makes it an
excellent candidate for probing large numbers of potential muta-
tions of marginally stable proteins to understand PQC response
to different conformations in silico and to guide in vivo experi-
ments. This analysis could also shed light on a possible func-
tional role for marginal stability, which may enable sensitive
modulation of expression through qualitative transitions in
conformational state.
To investigate the link between the underlying biophysics of
protein folding and the PQC fate of a model misfolded protein,
the burial mode model was used to investigate the folding char-
acteristics of the human VHL tumor suppressor protein. Burial
traces were calculated to predict exposed residues for the
lowest energy conformations of different mutations of VHL, 20
of which were generated experimentally and tested for their
degradation properties in vivo. One of these mutations had
markedly and consistently higher levels of VHL present at steady
state. Through the use of burial mode analysis, the structural ba-
sis of its enhanced ability to persist in the cell was characterized.
Our findings confirm that VHL sits on a structural tipping point in
sequence space, where a single mutation can lead to a qualita-
tive shift in folding stability, which leads to an altered quality con-
trol outcome. Not only do these results highlight the power of a
new computational model in gaining elusive information about
the structure of intrinsically disordered proteins, they also raise
the possibility that such proteins may generally be poised to
exhibit strong sensitivity to mutation in vivo, where small pertur-
bations can lead to large differences in the amount of folded pro-
tein that survives PQC supervision.
RESULTS
Our initial goal was to see if we could use computational
modeling of the VHL protein to design mutations that would alter
its misfolding and degradation. Since VHL is a human protein, it
lacks its elongin binding partners when expressed in yeast and
thus is quickly degraded. We began by using burial mode anal-
ysis to design mutations of VHL that would be expected to
reduce the misfolding propensity of the protein and thus slow
the degradation of the protein in the yeast cytosol.
Description of Biophysical Model
Our previous work presented a phenomenological framework to
estimate the burial trace or the distance of each amino acid from
the center of mass in the lowest energy fold of a globular poly-
peptide chain. This burial trace predictor assumes that each
amino acid behaves like it is connected by a spring to its
neighbor residues, simulating peptide bonds (Figure 1). These
springs contribute to the overall energy for the system, along
with the energetically favorable terms of putting hydrophilic res-
idues far from the center of the protein and burying hydrophobic
ones. This energy function can then be minimized through linear
optimization under geometric constraints, specifically to ensure
that the individual peptides are not clustered into a small volume
that would lead to prohibitive steric clashing in a physical sce-
nario. The calculation generally takes less than a second to run
for short sequences and results in a prediction of the distance
of each residue from the center of the protein in its lowest energy
state, called the burial trace.
Table 1. List of Mutants that Were Created Experimentally: Half
Were Chosen Based on aModel Parameter and Half Were Chosen
Randomly
Low Structural Variability Mutations Random Mutations
1. K171 P61 11. E173 K196
2. R176 G14 12. E70 G19
3. V20 R3 13. V155 G19
4. P99 V74 14. T124 K159
5. V66 P40 15. T157 V194
6. K171 P5 16. D28 A56
7. V20 R4 17. G93 V181
8. R167 A11 18. R69 S168
9. C162 N7 19. L201 E173
10. Q203 N109 20. S183 C162
Figure 1. Overview of Burial ModeModeling
(A) An amino acid chain can be modeled as points
connected by springs representing peptide bonds.
An energy function including costs for stretching
neighbor residues apart and putting hydrophobic
residues on the outside of the protein can be
minimized under our desired steric constraints to
predict low energy burial patterns.
(B) An example of a burial trace, plotting ameasure
of the distance of an amino acid from the center of
mass of the protein in its lowest energy confor-
mation versus the index of that amino acid in the
protein sequence.The relatively small size (213 residues) of VHL and the predom-
inance of a-helical structure in its non-disordered region make it
a good candidate for use of the burial mode model. As a first
attempt at modeling VHL stability, all

213
2

possible VHL
pair-swap mutations (where amino acids at two different loca-
tions in the sequence are switched, which preserves overall res-
idue frequencies for the sequence) were ranked according to a
parameter called structural variability. The hypothesis behind
our procedure was that VHL mutants that were less capable of
fluctuating between structurally different conformations at low
energy (i.e. at energies comparable with the thermal energy scale
kT above the energy of the optimal [native] configuration) were
less likely to be recognized as misfolded by the quality control
system. Accordingly, for each pair-swap mutation, we first
calculated the burial trace that was maximally different from
the optimal lowest energy trace at fixed, low energy. Then, we
ranked the mutations, and selected those ten for which this
maximized difference was smallest. This procedure yielded ten
least structurally variable mutants to test experimentally. We
also selected a control group of ten mutations that were
randomly chosen with uniform probability over all possible
pair-swap mutations. The complete set of mutations is listed
in Table 1.
All 20 mutations were then created in an S. cerevisiae consti-
tutive plasmid with an attached fluorescent Dendra2 tag and
transformed into budding yeast cells, which contain neither
native VHL protein nor the human elongin cofactors. If the VHL
protein were able to adopt a fold that is resistant to PQC degra-
dation, then the attached fluorescent tag would also be pre-
served and observable. Fluorescence was detected by using
quantitative flow cytometry (Figure 2A). A subset of these mu-
tants were then tagged with GFP and integrated into the genome
under the control of a galactose-operated promoter, and their
expression level was quantified by fluorescence microscopy at
steady-state levels (Figure 2B).
Despite how they were chosen, the first ten non-randomly
chosen mutations exhibited lower overall fluorescence than the
ten randomly chosen control mutations. This result could be in-
terpreted to mean that either the predictions of the burial mode
model were wrong or else that our chosen criterion for enhanced
VHL folding (low predicted structural variability) was the wrong
one. Had the random control set behaved no differently fromthe designed mutants, the trail would have gone cold at this
point. Surprisingly, however, two mutations in the random con-
trol set achieved greater than a 3-fold increase over the wild-
type sequence in the flow cytometry data. The mutant V155-
G19 (henceforth referred to as VHL13), which demonstrated
70% of the fluorescence of the Dendra2 tag alone, changed
a hydrophobic residue in the Box 2 region (spanning residues
148–155), which mediates the interaction of chaperonin TRiC
with VHL and replaced it with the smaller and more flexible
glycine, which is normally located in the disordered N-terminal
region. This mutation was distinct in our set because it was
the only one that directly affected a known chaperonin
binding site, which provided a natural rationale for its altered
degradation.
The mutant VHL19, L201-E173, however, exhibited the highest
level of fluorescence, with a 5-fold increase in steady-state levels
compared with the wild-type sequence and 85% of the base-
line Dendra2 level. The high steady-state levels of this mutation
were further confirmed in the fluorescence microscopy. The bio-
physical characteristics of the residues swapped were dissimi-
lar, with the hydrophobic leucine at residue 201 changing into
a negatively charged glutamic acid (normally at residue 173)
and vice versa. Although both mutations occurred in the region
that adopts a well-defined conformation during correct folding,
neither was in a known binding site for cofactors or chaperones,
raising the possibility that an allosteric response could explainStructure 23, 1169–1178, July 7, 2015 ª2015 The Authors 1171
Figure 2. Analysis of VHLMutant Stability by
Flow Cytometry and Fluorescence Micro-
scopy
(A) Fluorescence measurements by quantitative
flow cytometry for all experimentally created VHL
mutations and normalized to fluorescence of the
wild-type sequence. The orange entry indicates the
most stable mutant, VHL19 (L201-E173), in both
panels.
(B) Selected mutants were also introduced to
S. cerevisiae cells and expressed endogenously as
a GFP fusion construct, and observed directly by
fluorescence microscopy with results normalized
to GFP levels without VHL. Error bars for all sec-
tions represent SE. See also degradation curves in
Figure S1. a.u., arbitrary units.the structural change necessary to evade PQC degradation
systems.
Past work has established several interaction sites in the well-
folded region of VHL, including two short motifs called Box 1
(residues 114–118) and Box 2 (residues 148–155), which are
known to bind to chaperonins (Feldman et al., 2003), and a short
binding motif for cofactors of VHL elongin B and elongin C. A
BLAST search for VHL cofactors elongin B and elongin C also re-
vealed that although elongin B does not have a counterpart in
yeast, a homolog of elongin C is present. Furthermore, this ho-
molog has been shown to bind to a VHL fragment containing res-
idues from 157 to 171, which contains the known elongin B/C
binding site, in vitro (Botuyan et al., 2001). Since elongin B and
C stabilize VHL in human cells, one testable hypothesis is that
burying the chaperonin interaction sites (and therefore possibly
protecting VHL from chaperone-assisted degradation) and
exposing the elongin interaction site could help explain why
certain mutations caused the protein to resist degradation in
the cell.
To explore how mutations could affect conformations, partic-
ularly in understanding exposure patterns of different interaction
sites, the burial trace of each experimentally created mutant was
computed using the burial model and compared with the actual
burial trace calculated from the crystal structure of the well-
folded region. Since the basic burial trace model works best on
a-helical structures, each input sequence was truncated to resi-
dues 63–204, corresponding to the region that canbe crystallized
(PDB: 1VCB) in an attempt to improve accuracy within the region
that can adopt a well-defined folding state (Stebbins et al., 1999).
Figure 3 shows the predicted burial traces for the wild-type and
VHL19 sequences, along with maximal and minimal predicted
burial values at each residue for all 20 experimentally createdmu-
tations. The experimental burial trace obtained directly from the
crystal structure of wild-type VHL (PDB: 1VCB chain C) is also1172 Structure 23, 1169–1178, July 7, 2015 ª2015 The Authorsshown. The crystal structure burial trace
shows a distinctive burial of the Box 1
and Box 2 regions, suggesting that TRiC
uses these regions to recognize the failure
of the protein to fold natively. The elongin
binding site, meanwhile, is moderately
exposed compared with Box 1 and Box
2 in the native conformation.Of all the experimentally tested mutants, the well-stabilized
VHL19 mutation (Figure 3, orange line) is predicted to have the
most buried Box 1 and Box 2 regions, similar to how TRiC is
able to bury these motifs in achieving its native conformation in
human cells. Furthermore, the elongin interaction region of the
VHL19 mutation was distinctive in that the burial mode model
predicted that it was one of the most exposed regions in the
entire sequence. This property of burying known chaperone
interaction sites and exposing the cofactor binding site is unique
among the other mutant andwild-type sequences (Figure 3, gray
envelope and black line, respectively), and is more similar to the
known native conformation of the protein derived from its crystal
structure. To test the significance of this finding, we also calcu-
lated each possible pair-swap mutation in the region of VHL that
can be crystallized (residues 63–204) and compared their burial
traces by Pearson correlation with the burial trace of the crystal
structure. Only 6.18% of possible mutations in this region had a
higher correlation with the crystal structure than the VHL19
mutant (Figure 4A).
The two stabilizing mutants were unique in that they affected
chaperone binding sites, either through direct mutation, as in
the case of VHL13, or through causing the burial of these sites
to be more energetically favorable, as in VHL19. The other
distinctive component of the VHL19 burial trace, however,
was its extreme exposure of its elongin cofactor binding site.
We hypothesized that VHL19 evades degradation by combining
reduced chaperonin interaction with increased stabilization
through interaction with the elongin cofactor. Thus, we scored
all possible pair-swap mutations by ranking directly how well
the Box 1 and Box 2 chaperonin interaction regions were
buried and the elongin interaction site was exposed based on
the predictions of the burial model. This score can be obtained
from a mutated sequence by calculating the sum of the pre-
dicted distances of the most buried residues in the Box 1
Figure 3. Burial Mode Analysis of VHL
Mutants
(A) The crystal structure of parts of VHL can be
obtained when the protein is bound in complex to
cofactors like elongin C, which binds to VHL be-
tween residues 157 and 166. VHL also is known to
interact with chaperones in regions called Box 1
and Box 2.
(B) The VHL19 mutation (orange line) is predicted to
bury its Box 1 and Box 2 regions, suggesting a
conformation that is closer to the form the protein
takeswhenstablyboundaspart of theVBCcomplex
(green line). The elongin interaction site of the mu-
tation is also predicted to be highly exposed
comparedwithboth thewild-type (black line) and the
other experimental mutations (gray envelope). Lo-
cationsof specificmutations are shown inFigureS2.and 2 regions from the center of mass of the protein and adding
this subscore to the predicted distance of the maximally
exposed residue in the elongin interaction region from the
most exposed residue of the entire protein (Figure 4B). The
smallest score would correspond to Box 1 and Box 2 being
located at the center of the protein and the elongin interaction
site being on the most external part of the surface of the pro-
tein, which would in turn correspond to the hypothetically
best way of evading degradation by achieving greater folding
stability in the cell.
Amazingly, according to this scheme, VHL19 turned out to
have the lowest (most optimal) score of 10,000 possible mu-
tations (Figure 4C). The location of the other experimentally
determined mutants is also shown, indicating a large gap inStructure 23, 1169–1scores between mutant VHL19 and the
rest of the experimental sequences. The
scores of the rest of the sequences,
however, did not correlate with their fluo-rescence levels, indicating that this may be a binary effect
observed only at the extreme achieved by VHL19.
The homolog of elongin C, Elc1, is not an essential protein in
S. cerevisiae, so to test our hypothesis that the VHL19 mutation
helped stabilize the protein by decreasing chaperone interac-
tions and/or interacting with Elc1, the mutated VHL sequences
were transformed into an Elc1 knockout of yeast. Fluorescence
microscopy was again used to measure persistence of the VHL
mutant protein in the cell (Figure 5). The stable expression of
VHL19 in the knockout strain Delc1 was decreased to that of
the wild-type, indicating that Elc1 could be helping to stabilize
this mutation and lending credence to the findings of the burial
model. A plasmid containing human elongin B and C, known to
help stabilize VHL in humans, was then transformed to cellsFigure 4. Burial Pattern of VHL19 Is Distinct
from the Other Mutated Sequences
(A) Compared with all possible pair-swap muta-
tions in the region of VHL that can be crystallized
(residues 63–204), VHL19 (black arrow) is predicted
to have a higher burial pattern correlation with the
crystal structure than 93.82% of all other possible
mutations.
(B) An illustration of how scores were generated for
each possible mutant, where the smallest score
would correspond to maximal burial of the Box 1
and 2 regions andmaximal exposure of the elongin
interaction site.
(C) Each possible pair-swap mutation in the region
(63,204) was scored according to Figure 4B. VHL19
has the lowest (best) score out of 10,000 muta-
tions. The locations of the other experimental
mutants in the histogram are indicated by the gray
lines, with VHL19 marked by the orange line.
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Figure 5. Analysis ofMutant VHL Interaction
with Elc1 through Deletion and Overexpres-
sion
GFP constructs with VHL were expressed in wild-
type S. cerevisiae (gray, center in grouping), a
knockout strain for the yeast homolog of elongin C
Delc1 (light blue, leftmost in grouping), and in the
EBC OE strain, which introduced and overex-
pressed human versions of elongin B and C (dark
blue, rightmost in grouping). Although expressing
VHL19 in the Elc1 knockout strain decreased the
levels of the mutant VHL to that of wild-type VHL,
the presence of human elongin B and C markedly
increased VHL19 levels. Error bars represent SE in
all sections. Degradation curves for the wild-type
sequence under both EBC OE and knockout
conditions are also shown Figure S1. a.u., arbitrary
units.expressing the integrated VHL mutants and constitutively ex-
pressed (EBC OE strain). The presence of the natural cofactors
of VHL further stabilized the VHL19 mutant by 70%, providing
more evidence that the cofactor elongin homolog directly
contributes to the exceptional extra stability of the VHL19
mutant.
Having quantified fluorescent levels, we then looked more
closely at the cell biological phenotypes of the different
mutants. Further observation of the behavior of different
VHL mutants in the Delc1 environment revealed clear puncta
formation for most mutants, including VHL19, in the absence
of the yeast homolog of elongin C (Figure 6). Puncta formation
is linked to different aspects of the PQC system, including dif-
ferential processing of terminally misfolded proteins and as a
response to external and internal stress (Amen and Kagano-
vich, 2015; Narayanaswamy et al., 2009). Elongin C is itself
part of the polyubiquitination process, functioning as a
component of an E3 ubiquitin ligase complex in both yeast
and mammals and therefore directly contributing to PQC sys-
tems through its participation in ubiquitin-mediated degrada-
tion pathways (Lisztwan et al., 1999; Ramsey et al., 2004).
Intriguingly VHL13 (which had also exhibited high fluorescence
in the original flow cytometry experiment) escaped this cellular
phenotype, remaining diffuse throughout the cell. This VHL
sequence is the only one tested that changed a residue in a
known chaperonin binding site, indicating that this mutation
might be able to escape PQC recognition and avoid being
sequestered in puncta before degradation. This result is
certainly consistent with our original hypothesis that the higher
fluorescence of VHL13 was due to altered chaperonin
interaction.
DISCUSSION
The ability of a cell to recognize aberrant proteins and target
them for either refolding or destruction is crucial to maintaining
protein homeostasis and preventing pathological aggregation.
At the same time, allosteric interactions caused by relatively mi-
normutational changes can have a large impact on how a protein
is categorized by the PQC system. Consequently, an improved
understanding of how potential PQC substrates may be driven
between qualitatively different conformational states by various1174 Structure 23, 1169–1178, July 7, 2015 ª2015 The Authorsperturbations is essential to a full understanding of how the cell
maintains proteostasis.
A persistent challenge in studyingmanyPQC substrates is that
by nature they tend to be structurally disordered and are there-
fore not easily amenable to traditional methods of in vitro struc-
tural characterization (Oldfield and Dunker, 2014). As a result,
there is an opportunity for computational methods to play a cen-
tral role in providing valuable structural information that can be
used in combination with experimental results to better under-
stand how the PQC fate of misfolding-prone proteins may be
affected by mutation or stress. This study presents a novel
method of integrating computational biophysics techniques to
gain an experimentally testable glimpse into howmarginal stabil-
ity affects protein interactions with the PQC machinery. This
approach of using in silico results to guide in vivo experiments,
and vice versa, demonstrates that both approaches can be
used in tandem to yield better explanations for these biophysical
phenomena.
In particular, due to its marginal stability, VHL has been used
as a model substrate for chaperone proteins involved in assisted
folding pathways as well as for studying PQC systems. Hsp90,
Hsp70, and TRiC have all been shown to interact with VHL in
yeast, with the chaperonin TRiC potentially functioning as a hol-
dase for containing nascent VHL until it can bind to its elongin co-
factors (Feldman et al., 1999). Although TRiC has not been
directly implicated in the degradation processes, some mutant
forms of VHL have also been shown to be able to refold after
denaturing events in a chaperonin-independent way in vitro but
not in vivo (Feldman et al., 2003; Yang et al., 2013).
In this study, we present 20 novel pair-swap mutations of VHL
that switch the position of two residues in the sequence and
examine the protein products in yeast for a measure of their abil-
ity to escape rapid degradation by the cell. In particular, two mu-
tations caused VHL to be detected in much larger amounts than
that of transformed wild-type VHL: swapping the valine and
glycine residues at positions 155 and 19, respectively (VHL13),
and swapping the leucine and glutamic acid residues at posi-
tions 201 and 173 (VHL19). The first mutant directly affected a
chaperone binding site, while the second did not mutate resi-
dues in any known chaperone or cofactor interaction motifs.
Initially, these results were surprising because both stabilizing
mutations were chosen randomly as part of the control group,
Figure 6. Cellular Phenotype Resulting from Elc1 Knockout
Fluorescently tagged VHL mutants display a distinct cellular phenotype when expressed in the Delc1 strain compared with the wild-type strain. Different panels
show different mutant versions of VHL in both the wild-type (top) and Delc1 (bottom) strains, with green representing the fluorescent protein fusion construct and
red the vacuole. VHL4 and VHL5 could not be detected in the cell at appreciable quantities, and only GFP alone and VHL13 escaped the puncta phenotype
characterized by the other VHL forms.while the test group of ten mutants designed to exhibit more
stability actually produced less stable behavior on average.
The underlying rationale behind choosing this latter group of
mutants focused on predicting how easily a protein structure
could access different structures at a low energy, with the
idea that sequences displaying the least variability in predicted
structure also might indicate increased thermodynamic stability
and decreased degradation by the PQC system. The behavior
of these mutants in vivo illustrates the difficulty in teasing apart
the mechanisms of PQC response for marginally stable pro-
teins. In the case of the ten designed mutants, the lower than
expected observed amounts present in the cell may have
been indicative that the mutated sequences were kinetically
trapped in one configuration that was more easily identified by
the PQC system. An estimate between the random and non-
random sets bounded the probability of observing no highly
fluorescent hits in the non-random set while obtaining two or
more hits in the random control set at a maximum value slightly
below 0.1. It is possible that the structural variability calculations
actually predicted the opposite effect than originally thought:
namely, lower ability to persist in the cell rather than higher ther-
modynamic stability. In this case, our designed parameter to
maintain protein structure despite small energetic fluctuations
may have made these mutants more susceptible to degrada-
tion, underscoring the importance of examining how protein
conformational changes can affect the outcome of PQC interac-
tions. Future sequence design protocols along the lines of our
initial attempt should therefore be modified to include not only
the effect of structural variability but also the importance of
maintaining resemblance to a native fold that exposes the right
parts of the chain on the surface.To explain the two unexpectedly stable hits in the random con-
trol sample, the biophysical burial mode model was used to
examine each of the 20 mutated sequences. These structural
predictions were also compared with the wild-type sequence
and its experimentally determined structure. Strikingly, the burial
mode model predicted that the mutated sequence of VHL19
would fold such that it would bury known hydrophobic chap-
erone interaction sites while exposing a motif known to be
necessary and sufficient for binding to a homolog of its human
cofactor elongin C in yeast (Figure 3). The two chaperone inter-
action sites have been identified as binding to TRiC, with the first
motif also similar to the known Hsp70 recognition motif of a short
hydrophobic sequence flanked by charged residues (Ru¨diger
et al., 1997). Thus, one possible effect of the VHL19 mutation
could be to suppress interaction between the VHL protein and
the PQC machinery. Even more intriguingly, the burial mode
modeling also points to the possibility that this mutant form of
VHL is stabilized because of interactions with a cofactor homo-
log that does not stabilize the wild-type sequence. The cofactor
elongin C exists in yeast despite the absence of other VHL cofac-
tors, but previous studies had indicated that it does not increase
the half-life of wild-type VHL (McClellan et al., 2005). However,
when we introduced VHL19 into a yeast strain lacking the elongin
C homolog, levels of mutant VHL were decreased to that of the
wild-type protein, providing compelling experimental evidence
in support of the hypothesis that the yeast homolog of elongin
C does substitute for the effect of the human cofactor as pre-
dicted and stabilizes the VHL19 mutant. This hypothesized inter-
action between the elongin cofactor homolog Elc1 and VHL in
yeast was further supported when the different mutants were
examined by microscopy (Figure 6), since the absence of Elc1Structure 23, 1169–1178, July 7, 2015 ª2015 The Authors 1175
Table 2. Strains Used in this Study
Strain Genotype Reference
BY4741 BY4741 MATa his3del0
leu2del0 met15del0
ura3del0
Brachmann et al.,
1998
BY4741 Delc1 BY4741 MATa his3del0
leu2del0 met15del0
ura3del0 elc1::KANMX
Winzeler et al.,
1999
BY4741 GFP BY4741 his3::GALp-
GFP -HIS3
This study
BY4741 GFP-VHL
(wild-type or
mutants)
BY4741 his3::GALp-
GFP-VHL(wt or mutants)-HIS3
This study
Table 3. Plasmids Used in this Study
Plasmid Description Reference
pDK399 pESC-LEU-ELONGIN B/C This study
pDK2-22 pRS303-GAL1p GFP GAL10p nls-TFP This study
pDK2-(2-21) pRS303 GAL1p GFP-VHLwt or mutants
GAL10p nls-TFP
This study
pDK5 (1-21) pESC-URA GAL1p GFP-VHLwt or mutants
GAL10p nls-TFP
This study
pDK437 pRS316 GPDp DDR2 This study
pDK437 (2-21) pRS316 GPDp DDR2 -VHLwt or mutants This studygives rise to a new quality control phenotype in wild-type and
most mutated forms of VHL.
Using VHL as a model protein, the burial model has been
shown to be capable of providing explanations of the relative
likelihood of a mutated protein being degraded based on its
ability to adopt different conformational states. Furthermore,
this predictive capability was able to scan a large set of se-
quences in a relatively short time, providing rapid structural in-
formation about all possible mutations to narrow and refine
experimental studies. The effectiveness of the burial mode
model in explaining structural changes in mutant forms of
VHL has significant implications for the underlying physical
driving forces behind VHL stability. The model predicts struc-
tural change by calculating the trade-off between hydrophobic
and steric effects; thus, our findings point to the possibility that
the marginal stability of VHL originates in a fluctuating balance
struck among three distinct stretches of moderately hydropho-
bic sequence (Box 1, Box2, and the ELC-binding region) that
compete for limited space in the packed hydrophobic core of
the protein.
Meanwhile, the elevated levels of VHL13, V155-G19, that we
observed are more likely to have been the result of altered inter-
action with chaperones that directly followed from changes to
known chaperone binding sites. The fact that this mutant was
alone in escaping the puncta phenotype observed by micro-
scopy in other VHL variants in the Delc1 strain further illustrates
the complex interactions that characterize cellular PQC systems
involving both segregation and degradation of terminally mis-
folded proteins.
Stabilization both through modulation of chaperone interac-
tions and through cooperative interactions with binding partners
is implicated for VHL in determining how the PQC responds to
conformational variants. Past computational work has under-
lined the importance of allosteric conformational change to
VHL structure and function (Liu and Nussinov, 2008). Our find-
ings confirm the importance of these effects specifically in
connection to cofactor binding. Furthermore, this analysis also
raises the question of whether or not the susceptibility of a
marginally stable protein to adopting different structural forms
might be advantageous to the cell, since this differential folding
pattern based on small perturbations is directly coupled to
PQC response. For example, an enhanced sensitivity to muta-
tion can allow an additional level of cellular modulation of the
functional fold of a protein, or can contribute to the enhanced1176 Structure 23, 1169–1178, July 7, 2015 ª2015 The Authorsability of a protein to rapidly traverse an evolutionary landscape
to find potential new folds.
Expanding our computational and experimental analysis to
other proteins besides VHL may also prove informative in how
the PQC responds to other marginally stable proteins, and in
elucidating the importance of the structural flexibility of such a
protein in a cellular context. The well-characterized p53 protein
is similar to VHL in that it is small enough for burial trace analysis
(393 amino acids), includes an N-terminal intrinsically disordered
region, shows low thermodynamic and kinetic stability, and is
characterized by a large number (>1,000) of cancer-related mu-
tations found in humans (Joerger and Fersht, 2007). In addition, a
recent study has indicated that p53 interacts with the same
chaperonin, TRiC, that is involved in VHL folding (Trinidad
et al., 2013). The similarity of this protein to VHL, in terms of
both its functional properties and its clinical importance, makes
it an enticing target for burial analysis. Further exploration of the
structural basis of misfolded protein recognition, including of
client tumor suppressors like VHL and p53, can give new insights
into how cells maintain proteostasis and what structural mecha-
nisms can drive qualitative shifts in the PQC fates of marginally
stable proteins on the brink of structural disorder.
EXPERIMENTAL PROCEDURES
Yeast Strains, Growth Conditions, and Materials
Yeast growth, media preparation, and manipulations were performed accord-
ing to standard protocols (Adams et al., 1997). The strains used are listed in
Table 2.
Plasmids used in this study are summarized in Table 3. VHL gene was fused
toGFP or DDR2 andwas expressed under the control of a galactose-regulated
promoter (Gal1p); nls-TFP was used as a nuclear marker and expressed under
GAL10p.
Microscopy
For imaging, yeast cells were grown on galactose-containing medium to mid-
dle log phase and seeded on concanavalin A (Sigma)-coated four-well
microscope plates (IBIDI). Confocal 3D images were acquired using a dual
point-scanning Nikon A1R-si microscope equipped with a PInano Piezo stage
(MCL), using a 603 PlanApo VC oil objective NA 1.40. Calculations of the fluo-
rescence intensity and image processing were performed using NIS-Elements
software.
Single Cell Degradation Assay
Cells were grown as described earlier. The expression of GFP-VHL variants
was induced by switching to galactose-containingmedium for 6 hr. The degra-
dation was calculated as a decrease in the green fluorescence intensity after
cells were transferred to glucose medium (time 0). The fluorescence intensity
of single cells was calculated using NIS software. All data points were normal-
ized to GFP fluorescence decay under the same conditions.
Fluorescence-Activated Cell Sorting Analysis
Yeast strains were grown on selection medium for 2 days, diluted twice a day
to log phase, and on the third day, the fluorescence intensity of the DDR2 tag
fused to VHL was analyzed by fluorescence-activated cell sorting with a 488
laser using BD FACSDiva (BD Biosciences) software.
Mutagenesis
Different VHL mutants were cloned using a restriction-free cloning protocol as
described by Van den Ent and Lo¨we (2006). Briefly, primers were designed ac-
cording to the desired mutation and used for the first PCR reaction to amplify a
mega primer carrying twomutations on the VHL sequence.Mega primers were
used for a second PCR reaction to amplify the whole pDK5 plasmid with the
desired two mutations using high-fidelity DNA polymerase (KAPA KR0370).
Dpn1 digestion was used after the second PCR to get rid of the old methylated
plasmids leaving only the new mutated plasmids. VHL mutants were then
subcloned to pRS plasmids for fluorescence-activated cell sorting analysis.
Statistical Analysis
To compare the designed mutants with the control group, we estimated our
probability of the result arising from chance by calculating the number of hits
(fluorescence levels above a threshold T) in both the design and control group:
MaxðPðno hits>T in designed j fÞ3Pð2 or more hits>T in control j fÞÞ
where each probability is calculated as a binomial distribution arising from f,
the underlying fraction of hits expected to be seen above the threshold. For
the calculation in this study, the threshold was set at 60%.
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